Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Kontafarma China Holdings Ltd ( (HK:1312) ) has issued an update.
Kontafarma China Holdings Ltd announced that executive director Liu Jiankun has resigned effective 16 April 2026 to pursue other work commitments, and will also step down from the company’s executive committee and share dealing committee. The board emphasized there was no disagreement between Liu and the company, and expressed appreciation for his contributions during his tenure.
The company simultaneously appointed Ge Shouwen as an executive director, vice president of the group, and a member of both the executive committee and the share dealing committee, also effective 16 April 2026. Ge brings extensive experience in engineering construction, project management, and international business operations from senior roles at Shanxi Installation Group and related entities, a move likely aimed at strengthening Kontafarma’s operational and overseas project capabilities without increasing directors’ fee expenses, as he has agreed to waive a director’s fee.
More about Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd is a Hong Kong-listed company incorporated in the Cayman Islands, operating through a group structure in mainland China. The group focuses on its core businesses under the oversight of a board and various board committees, reflecting a typical diversified corporate governance framework for a mid-sized listed enterprise.
Average Trading Volume: 1,458,687
Technical Sentiment Signal: Sell
Current Market Cap: HK$167.4M
For an in-depth examination of 1312 stock, go to TipRanks’ Overview page.